RNS
CEMI

Robert N. Shapiro’s Chembio diagnostics, Inc. CEMI Stock Holding History

Robert N. Shapiro’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-875
Closed -$3K – 1037
2013
Q3 		$3K Buy
+875
New +$3.71K ﹤0.01% 966

Other funds holding CEMI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Robert N. Shapiro's CEMI Position: Q4 2013 in Review

Robert N. Shapiro sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2013, closing a stake of 875 shares — an estimated $3K sold.

Robert N. Shapiro first reported a position in CEMI in Q3 2013 and held it in 1 quarter. The position peaked at $3K in Q3 2013. 17 funds tracked by Wall St. Rank hold CEMI as of Q4 2013.

  • Robert N. Shapiro reported no remaining Chembio diagnostics, Inc. position as of Q4 2013 after selling out during the quarter.
  • Robert N. Shapiro sold 875 Chembio diagnostics, Inc. shares in Q4 2013, an estimated $3K.
  • Robert N. Shapiro first reported a position in Chembio diagnostics, Inc. in Q3 2013 and held it in 1 quarter.
  • Robert N. Shapiro's Chembio diagnostics, Inc. position peaked at $3K in Q3 2013.
  • 17 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2013.

Based on Robert N. Shapiro's 13F filing for Q4 2013, filed 6 Feb 2014.